Stay informed with the latest litigation news. Explore now

Teijin Pharma competitive analysis

Latest publications and patents of Teijin Pharma New

Explore the latest publications and patents granted to Teijin Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 6, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Teijin Pharma

Jan 16, 2019Polymorphs Of 2-(3-Cyano-4-Isobutyloxyphenyl)-4-Methyl-5-Thiazolecarboxylic Acid And Method Of Producing The SameRevoked
Jan 31, 2018Pyridine DerivativeNo Opposition Filed Within Time Limit

Explore Teijin Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 16, 2019Polymorphs Of 2-(3-Cyano-4-Isobutyloxyphenyl)-4-Methyl-5-Thiazolecarboxylic Acid And Method Of Producing The Same1

Latest PTAB cases involving Teijin Pharma New

Discover the latest PTAB cases involving Teijin Pharma, highlighting their recent legal challenges and patent disputes.

Top competitors of Teijin Pharma

Top competitors of Teijin Pharma based on patent oppositions.